Tagomics is a biotechnology startup founded in 2020 with the slogan "Decoding disease using multiomics." The company focuses on harnessing the power of multiomics to accelerate disease understanding and diagnosis. In its latest milestone, Tagomics secured a significant £6.70M Seed Round investment on 21 February 2024. The investment was led by a diverse group of notable investors, including Agilent Ventures, Illumina Ventures, IQ Capital, Calculus Capital, OMX Ventures, MEIF Proof-of-Concept & Early Stage Fund, Mercia Ventures, and Meltwind Advisory. This recent infusion of capital positions Tagomics for further growth and development in its mission to revolutionize disease decoding through multiomics.
Tagomics
Decoding disease using multiomics
Founded 2020
19 employees
Seed
Total: $6.70M
Biotechnology, Life Sciences
General Information
Get notified when Tagomics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Tagomics
Get real-time alerts for funding, hiring, news, and 40+ signal types.
Start Tracking — FreeDiscover More
Biotechnology
About Tagomics
Taxonomy: multiomics, disease understanding, diagnosis acceleration, multiomic profiling, disease decoding
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | •••••• | 8 |
|
21 Feb 2024 |
Tagomics Alternatives & Competitors
Tagomics vs
Tagomics vs
MitoRx Therapeutics
United Kingdom
Developing new treatments to restore healthy mitochondrial metabolism in patients living with high-r...
Seed
17 employees
Biotechnology, Health and Wellness
Tagomics vs
T3D Therapeutics, Inc.
United States
Developing a potentially disease-modifying, new drug treatment for Alzheimer’s and other neurodegene...
Series Unknown
12 employees
Biotechnology
FAQ About Tagomics
Decoding disease using multiomics
Tagomics was founded in 2020.
Tagomics operates in the following industries: Biotechnology, Life Sciences.
Tagomics has approximately 19 employees.
Tagomics has completed 1 funding round, raising a total of $6.70M. The latest funding stage is Seed.
Top alternatives and competitors to Tagomics include RespiQ, MitoRx Therapeutics, T3D Therapeutics, Inc., G3P, Avolynt, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Tagomics and RespiQ are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors Tagomics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.